107228-53-5 Usage
Uses
Used in Pharmaceutical Synthesis:
3,6-dichloro-4,5-diethylpyridazine is used as an intermediate in the synthesis of various pharmaceuticals for its unique chemical properties and reactivity. It can contribute to the development of new drugs with specific therapeutic effects.
Used in Materials Science:
In the field of materials science, 3,6-dichloro-4,5-diethylpyridazine is used as a building block for the creation of new materials with tailored properties. Its incorporation into different structures can lead to the development of advanced materials with applications in various industries.
Used in Chemical Research:
3,6-dichloro-4,5-diethylpyridazine serves as a subject of study in chemical research, where its reactivity, stability, and interactions with other compounds are investigated. This research can provide insights into the compound's potential applications and guide the development of safer and more effective uses.
Check Digit Verification of cas no
The CAS Registry Mumber 107228-53-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,7,2,2 and 8 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 107228-53:
(8*1)+(7*0)+(6*7)+(5*2)+(4*2)+(3*8)+(2*5)+(1*3)=105
105 % 10 = 5
So 107228-53-5 is a valid CAS Registry Number.
InChI:InChI=1/C8H10Cl2N2/c1-3-5-6(4-2)8(10)12-11-7(5)9/h3-4H2,1-2H3
107228-53-5Relevant academic research and scientific papers
TRIAZOLOPYRIDAZINES AS PAR1 INHIBITORS, PRODUCTION THEREOF, AND USE AS MEDICAMENTS
-
Page/Page column 54, (2011/02/26)
The invention relates to novel compounds of formula I where R1, R2, R3, R4, R5, R6, R7, R8, Q1, Q2 and Q3 are each as defined below. The compounds of formula I have antithrombotic activity and inhibit especially protease-activated receptor 1 (PAR1). The i
TRIAZOLIUM SALTS AS PAR1 INHIBITORS, PRODUCTION THEREOF, AND USE AS MEDICAMENTS
-
Page/Page column 34, (2011/02/26)
The invention relates to novel compounds of formula I where X, A?, Q1, Q2 Q3, R2, R3, R4, R5, R6, R7, R8 and R9 are each as defined below. The compounds of formula I have antithrombotic activity and inhibit especially protease-activated recepto
Preparation of substituted pyridazines
-
, (2008/06/13)
A novel process is described for preparing substituted pyridazines, where a less substituted pyridazine is reacted with a carboxylic acid in the presence of a silver ion as catalyst, using peroxydisulfate ion. The reaction is run at a temperature from about 40° to 80° C. in an aqueous solvent system and mineral acid. The substituted pyridazines are useful as intermediates to herbicidal and fungicidal compounds.
